-
Symbol
-
LYEL on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
1.04M shares
-
Security Ownership
-
5.6%
Gates Frontier, LLC ownership in Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share (LYEL)
2025-08-01 - Gates Frontier, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.04M shares of Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share (LYEL).
This represents 5.6% percent ownership of the company.